Biotech Calendar: Key Dates for December
A calendar of important, potentially stock-moving biotech events for December.
09:56AM 11/30/09
Biotech Stock Mailbag: Cyclacel Pharma
Adam details his whereabouts on Sept. 9 and tackles readers' questions about Cyclacel, Epicept and a few more familiar names.
07:00AM 09/18/09
Weighing Arena's Obesity Drug: Biotech Mailbag
Readers weigh in on Arena Pharmaceuticals' obesity drug, Affymax's stock, and Cell Therapeutics' pixantrone.
07:00AM 09/04/09
FDA Panel Recommends Approval for Allos Cancer Drug
10-4 vote positive vote for lymphoma drug pralatrexate
04:57PM 09/02/09
FDA Panel Rejects Vion Leukemia Drug
Concerned about safety, panel asks for another trial to be conducted
04:35PM 09/01/09
Biotech Mailbag: Biocryst, Anadys, Allos, Amag
Readers weigh in on Biocryst's flu drug, the forecast for Alzheimer's drugs, Allos' prognosis, and shy AMAG's stock is getting pummeled.
07:00AM 08/21/09
Biotech Calendar: Key Dates and Events
A quick and dirty guide to important biotech events for the busy month of September.
09:00AM 08/18/09
Dendreon, Vion and Allos: Biotech Mailbag
Take profits on Vion Pharmaceuticals; nothing to worry about in Dendreon's dip; still bullish on Allos Therapeutics; YM Biosciences is too much loved.
07:00AM 08/14/09
Biotech Calendar: Key FDA Action Dates
A quick and dirty guide to upcoming FDA approval dates for biotech drugs.
11:57AM 08/05/09
Biotech Calendar: Key FDA Action Dates
A quick and dirty guide to upcoming FDA approval dates for biotech drugs.
12:07PM 06/03/09
Feuerstein's Biotech-Stock Mailbag
Vion has gone further downhill, while Arena can't find a catalyst.
10:24AM 03/22/08
Feuerstein's Biotech-Stock Mailbag
This week: Small-cap stocks garner reader attention.
11:43AM 10/27/07
Feuerstein's Biotech-Stock Mailbag
This week: Biogen Idec and Neurocrine Biosciences.
11:24AM 10/06/07
Stockpickr Lists: Cypress Bioscience
The biopharmaceutical company's shares nearly doubled after a successful study and an upgrade.
12:09AM 08/07/07
Thursday's Health Winners & Losers
NitroMed slumps on news of a 7.6 million-share stock offering.
12:09AM 08/07/07



Connect with TheStreet